16 Nov 2022 , 02:47 PM
Net profit of Vivo Bio Tech declined 57.14% to Rs 0.12 crore in the quarter ended September 2022 as against Rs 0.28 crore during the previous quarter ended September 2021. Sales rose 24.58% to Rs 12.67 crore in the quarter ended September 2022 as against Rs 10.17 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 12.67 | 10.17 | 25 |
| OPM % | 36.78 | 37.76 | – |
| PBDT | 2.88 | 2.80 | 3 |
| PBT | 0.51 | 1.07 | -52 |
| NP | 0.12 | 0.28 | -57 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
